Home LiteratureArticle Details
PMID: 21355092 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A.

Blood ·Vol. 117 ·No. 22 ·2011-06-02 ·Pages 6024-35

Joyal JS, Sitaras N, Binet F, Rivera JC, Stahl A, Zaniolo K, Shao Z, Polosa A, Zhu T, Hamel D, Djavari M, Kunik D, Honoré JC, Picard E, Zabeida A, Varma DR, Hickson G, Mancini J, Klagsbrun M, Costantino S, Beauséjour C, Lachapelle P, Smith LE, Chemtob S, Sapieha P

Abstract

The failure of blood vessels to revascularize ischemic neural tissue represents a significant challenge for vascular biology. Examples include proliferative retinopathies (PRs) such as retinopathy of prematurity and proliferative diabetic retinopathy, which are the leading causes of blindness in children and working-age adults. PRs are characterized by initial microvascular degeneration, followed by a compensatory albeit pathologic hypervascularization mounted by the hypoxic retina attempting to reinstate metabolic equilibrium. Paradoxically, this secondary revascularization fails to grow into the most ischemic regions of the retina. Instead, the new vessels are misdirected toward the vitreous, suggesting that vasorepulsive forces operate in the avascular hypoxic retina. In the present study, we demonstrate that the neuronal guidance cue semaphorin 3A (Sema3A) is secreted by hypoxic neurons in the avascular retina in response to the proinflammatory cytokine IL-1β. Sema3A contributes to vascular decay and later forms a chemical barrier that repels neo-vessels toward the vitreous. Conversely, silencing Sema3A expression enhances normal vascular regeneration within the ischemic retina, thereby diminishing aberrant neovascularization and preserving neuroretinal function. Overcoming the chemical barrier (Sema3A) released by ischemic neurons accelerates the vascular regeneration of neural tissues, which restores metabolic supply and improves retinal function. Our findings may be applicable to other neurovascular ischemic conditions such as stroke.

MeSH Terms
Animals Aorta/cytology,drug effects,metabolism Blotting, Western Cell Adhesion Cell Movement Cell Proliferation Cells, Cultured Disease Models, Animal Endothelium, Vascular/cytology,drug effects,metabolism Immunoenzyme Techniques Interleukin-1beta/pharmacology Ischemia/metabolism,pathology Mice Mice, Inbred C57BL Neovascularization, Pathologic Neurons/metabolism,pathology Oxygen/toxicity RNA, Messenger/genetics Rats Regeneration Retinal Diseases/etiology,metabolism,pathology Retinal Ganglion Cells/drug effects,metabolism Retinal Neovascularization Reverse Transcriptase Polymerase Chain Reaction Semaphorin-3A/physiology
Chemicals
Interleukin-1beta RNA, Messenger Semaphorin-3A Oxygen
Authors & Affiliations
25 authors, click to expand affiliations / ORCID
Joyal Jean-Sébastien
Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
Sitaras Nicholas
Binet François
Rivera Jose Carlos
Stahl Andreas
Zaniolo Karine
Shao Zhuo
Polosa Anna
Zhu Tang
Hamel David
Djavari Mikheil
Kunik Dario
Honoré Jean-Claude
Picard Emilie
Zabeida Alexandra
Varma Daya R
Hickson Gilles
Mancini Joseph
Klagsbrun Michael
Costantino Santiago
Beauséjour Christian
Lachapelle Pierre
Smith Lois E H
Chemtob Sylvain
Sapieha Przemyslaw
References (56)
56 references, click to expand
  1. Treatment of retinal diseases with VEGF antagonists.
    Prog Brain Res. 2009;175:253-67 PMID: 19660661
  2. A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis.
    Cytokine Growth Factor Rev. 2005 Aug-Oct;16(4-5):535-48 PMID: 15979925
  3. Cellular and molecular mechanisms of neural repair after stroke: making waves.
    Ann Neurol. 2006 May;59(5):735-42 PMID: 16634041
  4. PDGF mediates a neuron-astrocyte interaction in the developing retina.
    Neuron. 1996 Dec;17(6):1117-31 PMID: 8982160
  5. Neuropilins: novel targets for anti-angiogenesis therapies.
    Cell Adh Migr. 2007 Apr-Jun;1(2):56-61 PMID: 19329879
  6. Injury-induced class 3 semaphorin expression in the rat spinal cord.
    Exp Neurol. 2002 May;175(1):61-75 PMID: 12009760
  7. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.
    J Clin Invest. 2010 Aug;120(8):2684-98 PMID: 20664171
  8. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function.
    Nature. 2003 Jul 24;424(6947):391-7 PMID: 12879061
  9. Retinopathy of prematurity.
    Angiogenesis. 2007;10(2):133-40 PMID: 17332988
  10. The mouse retina as an angiogenesis model.
    Invest Ophthalmol Vis Sci. 2010 Jun;51(6):2813-26 PMID: 20484600
  11. Expressions of neuropilin-1, neuropilin-2 and semaphorin 3A mRNA in the rat brain after middle cerebral artery occlusion.
    Brain Res. 2001 Sep 28;914(1-2):1-14 PMID: 11578592
  12. ISCEV Standard for full-field clinical electroretinography (2008 update).
    Doc Ophthalmol. 2009 Feb;118(1):69-77 PMID: 19030905
  13. Early manifestations of postnatal hyperoxia on the retinal structure and function of the neonatal rat.
    Invest Ophthalmol Vis Sci. 2008 Jan;49(1):458-66 PMID: 18172126
  14. Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy.
    Br J Ophthalmol. 1996 Feb;80(2):168-73 PMID: 8814750
  15. Potential role of microglia in retinal blood vessel formation.
    Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3595-602 PMID: 16877434
  16. Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium.
    Graefes Arch Clin Exp Ophthalmol. 2004 Apr;242(4):321-6 PMID: 14722782
  17. Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach.
    Med J Aust. 1951 Jul 14;2(2):48-50 PMID: 14874698
  18. Kinase-dependent differentiation of a retinal ganglion cell precursor.
    Invest Ophthalmol Vis Sci. 2006 Jan;47(1):427-38 PMID: 16384993
  19. Cytokines in the vitreous of patients with proliferative diabetic retinopathy.
    Am J Ophthalmol. 1992 Dec 15;114(6):731-6 PMID: 1463043
  20. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
    Ocul Immunol Inflamm. 2005 Sep-Oct;13(5):375-81 PMID: 16422002
  21. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.
    J Cell Biol. 1999 Jul 12;146(1):233-42 PMID: 10402473
  22. The neurovascular retina in retinopathy of prematurity.
    Prog Retin Eye Res. 2009 Nov;28(6):452-82 PMID: 19563909
  23. Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development.
    FASEB J. 2001 May;15(7):1215-7 PMID: 11344092
  24. Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy.
    Am J Pathol. 2010 Dec;177(6):2715-23 PMID: 21056995
  25. L-arginine transport in retinas from streptozotocin diabetic rats: correlation with the level of IL-1 beta and NO synthase activity.
    Vision Res. 1999 Nov;39(23):3817-23 PMID: 10748917
  26. Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex.
    Exp Neurol. 2005 Jun;193(2):291-311 PMID: 15869933
  27. Pathogenesis of retinopathy of prematurity.
    Growth Horm IGF Res. 2004 Jun;14 Suppl A:S140-4 PMID: 15135797
  28. Proliferative retinopathies: angiogenesis that blinds.
    Int J Biochem Cell Biol. 2010 Jan;42(1):5-12 PMID: 19836461
  29. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis.
    Nat Protoc. 2009;4(11):1565-73 PMID: 19816419
  30. Mechanisms of endothelial cell guidance and vascular patterning in the developing mouse retina.
    Prog Retin Eye Res. 2006 May;25(3):277-95 PMID: 16515881
  31. Isomer-specific contractile effects of a series of synthetic f2-isoprostanes on retinal and cerebral microvasculature.
    Free Radic Biol Med. 2004 Jan 15;36(2):163-72 PMID: 14744628
  32. Computer-aided quantification of retinal neovascularization.
    Angiogenesis. 2009;12(3):297-301 PMID: 19757106
  33. Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke.
    Brain Res. 2007 Feb 9;1132(1):185-92 PMID: 17188664
  34. Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models.
    J Clin Invest. 2009 Nov;119(11):3356-72 PMID: 19809158
  35. Iron overload and gene expression in HepG2 cells: analysis by differential display.
    FEBS Lett. 2000 Mar 10;469(2-3):208-12 PMID: 10713272
  36. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia.
    J Neurosci. 1995 Jul;15(7 Pt 1):4738-47 PMID: 7623107
  37. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.
    J Biol Chem. 2007 Sep 7;282(36):26294-305 PMID: 17569671
  38. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain.
    J Biol Chem. 2002 Jul 5;277(27):24818-25 PMID: 11986311
  39. Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity.
    J Biol Chem. 2009 Nov 13;284(46):32066-74 PMID: 19762474
  40. Oxygen-induced retinopathy in the mouse.
    Invest Ophthalmol Vis Sci. 1994 Jan;35(1):101-11 PMID: 7507904
  41. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development.
    Dev Cell. 2003 Jul;5(1):45-57 PMID: 12852851
  42. Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse.
    J Neurosci. 1998 Nov 15;18(22):9282-93 PMID: 9801367
  43. Short communication: PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy.
    Circ Res. 2010 Aug 20;107(4):495-500 PMID: 20634487
  44. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
    Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10457-61 PMID: 7479819
  45. Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life.
    J Clin Invest. 2010 Sep;120(9):3022-32 PMID: 20811158
  46. The role of neuropilin in vascular and tumor biology.
    Adv Exp Med Biol. 2002;515:33-48 PMID: 12613541
  47. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis.
    Nat Med. 2008 Oct;14(10):1067-76 PMID: 18836459
  48. Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke.
    Stroke. 2007 Feb;38(2 Suppl):827-31 PMID: 17261747
  49. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis.
    Nat Med. 2007 Jul;13(7):868-873 PMID: 17589522
  50. Effects of hyperoxia on microvascular cells in vitro.
    In Vitro Cell Dev Biol. 1987 Feb;23(2):123-8 PMID: 2434458
  51. Functional and structural changes resulting from strain differences in the rat model of oxygen-induced retinopathy.
    Invest Ophthalmol Vis Sci. 2009 May;50(5):2436-50 PMID: 19168901
  52. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart.
    Nature. 1996 Oct 10;383(6600):525-8 PMID: 8849723
  53. Diabetes, diabetic angiopathy, and growth hormone.
    Lancet. 1970 Jul 18;2(7664):131-3 PMID: 4194508
  54. Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy.
    Retina. 2001;21(5):469-77 PMID: 11642376
  55. Common mechanisms of nerve and blood vessel wiring.
    Nature. 2005 Jul 14;436(7048):193-200 PMID: 16015319
  56. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity.
    Nat Med. 1995 Oct;1(10):1024-8 PMID: 7489357
Article Info
Journal
Blood
Abbr.
Blood
ISSN
1528-0020
Published
2011-06-02
Epub
2011-00-25
Pages
6024-35
Language
English
Region
United States
NLM ID
7603509
PMCID
PMC3112046
Subset
IM
Grants
NEI NIH HHS · EY017017 · United States
CIHR · Canada
NEI NIH HHS · R01 EY022275 · United States
NICHD NIH HHS · P01 HD18655 · United States
NICHD NIH HHS · P30 HD018655 · United States
NEI NIH HHS · EY017017-04S1 · United States
NEI NIH HHS · R01 EY017017 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]